Brackenridge's Medical Selection of Life Risks

Sixth Auflage 2028
ISBN: 978-3-032-20220-8
Verlag: Palgrave Macmillan

Buch, Englisch, 1180 Seiten, Format (B × H): 210 mm x 279 mm

The sixth edition of this leading reference book on insurance medicine provides a comprehensive guide to life expectancy for underwriters and clinicians involved in the life insurance industry. Extensively revised and expanded, the new edition reflects developments in life and healthcare insurance as well as medicine. Almost 20 years since it's last edition, each chapter is significantly updated to include the latest advancements in each disease, risk selection, and classification. Additionally, new content has been added to include rare disorders, the impact of climate and environmental changes on insurance medicine, screening for diseases and risk of disease, and critical illness. The impact of AI and other advanced technologies is also be discussed. 

Zielgruppe

Research

Autoren/Hrsg.

Richie, Rodney

Moore, Michael

MacKenzie, Ross

Weitere Mitwirkende

Zimmerman, Daniel

Fachgebiete

• Wirtschaftswissenschaften Wirtschaftswissenschaften Wirtschaftswissenschaften: Allgemeines
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizinrecht, Gesundheitsrecht
• Rechtswissenschaften Öffentliches Recht Medizin- und Gesundheitsrecht
• Mathematik | Informatik Mathematik Stochastik
• Interdisziplinäres Wissenschaften Wissenschaften: Forschung und Information Risikobewertung, Risikotheorie
• Wirtschaftswissenschaften Betriebswirtschaft Management

Inhaltsverzeichnis

Miscellaneous Impairments.- Rheumatic Diseases.- A Historical Survey of the Development of Life Assurance.- Types of Life and Health Insurance Policies and Risk Considerations.- Principles of Risk Selection and Classification.- The Application of Life Table Methodology to Risk Appraisal.- The Rating of Substandard Lives.- Genetics and Insurance.- Older Age Underwriting.- Underwriting Younger Ages: Pediatric Mortality Risk Evaluation.- Disability Income (Underwriting and Benefits).- Long-term Care Underwriting.- 
Critical Illness Insurance.- Evaluation of Kidney and Urinary Tract Conditions.- Impaired Life Annuities.- Structured Settlements.- 
The Underwriting Process.- Life Underwriting and Information Technology.- Underwriting Rare Diseases.- The Concept of Health and Disease.- The History and Physical Examination.- Laboratory Testing and Risk Classification.- Build.- Blood Pressure.- Diabetes Mellitus.- Cardiovascular Disorders: Part A: Cardiology Fundamentals: Murmurs, Imaging, Enlargement, and Hypertrophy.- Cardiovascular Disorders Part B: Electrocardiography.- Cardiovascular Disorders: Part C - Coronary Heart Disease.- Cardiovascular Disorders: Part D: Valvular Disorders.- Cardiovascular Disease: Part E.- Cardiovascular Disorders Part F: Vascular and Other Cardiac Disorders.- Cardiovascular Disorders: Part G - Arrhythmias.- Cardiovascular Disorders: Part H - Congenital Heart Disease.- Respiratory Disorders.-  Diseases of the Liver and Gastrointestinal Tract: Part A - Liver and Biliary System.- Diseases of the Liver and Gastrointestinal Tract.- Diseases of the Liver and Gastrointestinal Tract: Part C – Small and Large Intestines.- Oncology.- Diseases of the Blood.- Endocrine Disorders.- Diseases of the Nervous System.- Psychiatric Disorders.- Substance Abuse, Part A: Drugs and Alcohol.- Part B: Tobacco and Nicotine.- Musculoskeletal Disorders.- Infectious Diseases.- Post-Acute Infection Syndrome (PAIS).- Tropical Diseases.- Pregnancy and Female Reproductive Disorders.

Über Autor(innen)

Daniel D. Zimmerman , M.D., is Senior Vice President and Executive Medical Editor and Advisor for RGA Reinsurance Company. In this role, he serves as the Editor-in-Chief of 2026 revision and advises senior corporate leadership on scientific and medical topics.  He is also a member of the board of the International Committee for Insurance Medicine (ICLAM). 

Dan previously served as the Managing Director of The Longer Life Foundation, www.longerlife.org. This not-for-profit collaboration between RGA and Washington University School of Medicine in St. Louis funds the study of factors that either predict the mortality and morbidity of select populations or influence improvements in longevity, health, and wellness.

Prior to his current role, Dan was Head of Global Medical and Chief Science Advisor, where he was responsible for thought and medical leadership, case consultation, product development, client support, training and education, and executive advising. Before joining RGA, he was a medical director with Northwestern Mutual Life Insurance Company and had previously practiced primary care internal medicine and pediatrics in Tampa, Florida. 

Dan received his medical degree from the University of Wisconsin School of Medicine and Public Health and his undergraduate degree in Medical Microbiology and Molecular Biology from the University of Wisconsin – Madison, Wisconsin (U.S.). Professional certifications currently maintained include those from the American Board of Pediatrics, American Board of Internal Medicine, and the Board of Insurance Medicine.  He has held leadership positions with the American Council of Life Insurers (ACLI), participated in program committees of the American Academy of Insurance Medicine (AAIM), and frequently represents RGA to key industry professional organizations. He has also contributed several articles to the , and .  

Rodney C. Richie , M.D., is the Editor-in-Chief of the American Academy of Insurance Medicine's . He is a past medical director of both the Texas Life Insurance Company and EMSI. He has been an active member of the American Academic of Insurance Medicine (AAIM) for almost four decades. 

Michael L. Moore , M.D., is Chief Medical Director of Nationwide Insurance in Columbus, Ohio. 

Ross MacKenzie , M.D., is the current Editor Emeritus of the American Academy of Insurance Medicine's . Dr. MacKenzie spent most of his career as a board-certified cardiologist in Canada.